Risk factors | Energy [OR;95%CI] | Pain [OR;95%CI] | Emotional reaction [OR;95%CI] | Sleep [OR;95%CI] | Social isolation [OR;95%CI] | Physical mobility [OR;95%CI] |
---|---|---|---|---|---|---|
Age | 1.1; 1.0–1.1 | (> 76), 2.8; 1.7–4.9 | (> 79), 2.6; 1.4–4.8 | 1.1; 05–1.2 | (> 70), 5.6; 1.9–16.7), | 1.1; 1.08–1.2 |
Female gender | 2.2; 1.4–3.6 | 2.3; 1.4–3.9 | 2.9; 1.6–5.7 | 2.7; 1.6–4.3 | ||
Lower potassium 1 | 0.4; 0.2–0.7 | |||||
Higher creatinine 2 | 2.7; 1.3–5.7 | |||||
BMI 3 | 1.1; 1.0–1.2 | 1.0; 1.0–1.1 | ||||
History of syncope | 2.1; 1.0–4.1 | |||||
Advanced NYHAclass | 2.3; 1.4–4.0 | 2.0; 1.2–3.3 | 1.7; 1.1–2.8 | |||
Lower hemoglobine | (< 13) 2.0; 1.2–3.5 | |||||
History of MI 4 | 3.2; 1.3–7.5 | |||||
COPD 5 | 2.6; 1.3–5.3 | |||||
Previous CABG | 6.2; 4.5–7.9 | |||||
De Ritis-ratio (AST/ALT) 6 | 1.6; 1.1–2.4 | |||||
Neurological disorders | 2.2; 1.0–4.8 | 3.7; 1.5–8.7 | ||||
Concomitant CABG | 1.7; 1.01–2.8 | |||||
Higher urea7 | 1.01; 1.0–1.04 | |||||
Non-elective procedure | 2.5; 1.4–4.7 | |||||
Pacemaker before AVR | 10.5; 1.1–99.6 | |||||
Mean gradients (1 mmHg) | 1.1; 1.0–1.1 |